Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-4 of 4
Keywords: advanced glycation end-product (AGE)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2011) 121 (2): 43–55.
Published: 04 April 2011
... and extracellular formation of AGEs (advanced glycation end products). AGEs represent a heterogeneous group of proteins, lipids and nucleic acids, irreversibly cross-linked with reducing sugars. AGEs are implicated in the atherosclerotic process, either directly or via receptor-mediated mechanisms, the most...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (2): 81–89.
Published: 08 October 2010
... advanced glycation end-product (AGE) biomarker soluble receptor for advanced glycation end-product (sRAGE) Type 2 diabetes mellitus Long-term hyperglycaemia accelerates the formation and accumulation of AGEs (advanced glycation end-products) and leads to the over-expression of their cellular...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (8): 621–637.
Published: 16 March 2009
... Society 2009 advanced glycation end-product (AGE) diabetes gene polymorphism receptor for advanced glycation end-products (RAGE) vascular disease The first evidence to implicate a role for RAGE in the pathogenesis of vascular disease was initial studies in rats which investigated...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 109 (5): 439–446.
Published: 24 October 2005
... testing using Tukey's test. Statistical significance was taken as P <0.05 (two-tailed). advanced glycation end-product (AGE) citrulline assay diabetes glucose nitric oxide synthase O-glycosylation serine phosphorylation NOS-3 protein expression was determined in HUVECs by Western...
